The retinoblastoma gene (rb1) in acute myeloid leukaemia: Analysis of gene rearrangements, protein expression and comparison of disease outcome

British Journal of Haematology

Volumn 94, Issue 2, 1996, Pages 342-351

  Jamal, Rahman ^a   Gale, Rosemary E ^a   Thomas, N Shaun B ^a   Wheatley, Keith ^b   Linch, David C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

AML; pRB; RB1; rearrangements; survival

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE REARRANGEMENT; HUMAN; MAJOR CLINICAL STUDY; POINT MUTATION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; ACUTE MYELOBLASTIC LEUKEMIA; DELETION MUTANT; ENZYME POLYMORPHISM; FEMALE; GENETIC ANALYSIS; HUMAN CELL; LEUKEMIA REMISSION; MALE; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; RB1 GENE; SURVIVAL;

DNA; RETINOBLASTOMA PROTEIN;

EID: 0029886284     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1804.x     Document Type: Article

References (42)

1. Ahuja, B., Jat, P., Foti, A., Bar-Eli, M. & Cline, M.J. (1991) Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemia. Blood, 78, 3259-3268.
2. Belka, C., Greger, V., Zabel, B. & Horsthemke, B. (1991) No evidence for sequences structurally related to the RB1 gene in the human genome. Human Genetics, 86, 401-403.
3. Bishop, J.M. (1987) The molecular genetics of cancer. Science, 235, 305-311.
4. Bookstein, R., Lai, C., To, H. & Lee, W.H. (1990a) PCR-based detection of a polymorphic BamHI site in intron 1 of the human retinoblastoma (RB) gene. Nucleic Acids Research, 18, 1666.
5. Bookstein, R., Rio, P., Madreperla, S., Hong, F., Allred, C., Grizzle, W. & Lee, W.H. (1990b) Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proceedings of the National Academy of Sciences of the United States of America, 87, 7762-7766.
6. Buchkovich, K., Duffy, L. & Harlow, E. (1989) The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell, 58, 1097-1105.
7. 1 cells arrested with alpha-interferon. Oncogene, 7, 783-788.
8. Cairns, P., Proctor, A. & Knowles, M. (1991) Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma. Oncogene, 6, 2305-2309.
9. Chellapan, S., Hiebert, S., Mudryj, M., Horowitz, J. & Nevins, J. (1991) The E2F transcription factor is a cellular target for the RB protein. Cell 65, 1053-1061.
10. Chen, Y., Chen, P., Yeh, S., Tien, H., Wang, C., Tang, J. & Hong, R. (1990) Deletion of the human retinoblastoma gene in primary leukemias. Blood, 76, 2060-2064.
11. DeCaprio, J., Ludlow, J., Lynch, D., Furukawa, Y., Griffin, J., Piwnica-Worms, H., Huang, C. & Livingston, D. (1989) The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell, 58, 1085-1095.
12. Ginsberg, A., Raffeld, M. & Cossman, J. (1991) Inactivation of the retinoblastoma gene in human lymphoid neoplasms. Blood, 77, 853-840.
13. Godbout, R., Dryja, T., Squire, J., Gallie, B. & Phillips, R. (1983) Somatic inactivation of genes on chromosome 13 is a common event in retinoblastoma. Nature, 304, 451-453.
14. Goodrich, D. & Lee, W.H. (1993) Molecular characterization of the retinoblastoma susceptibility gene. Biochimica et Biophysica Acta, 1155, 43-61.
15. Haas-Kogan, D., Kogan, S., Levi, D., Dazin, P., T'Ang, A., Fung, Y. & Israel, M. (1995) Inhibition of apoptosis by the retinoblastoma gene product. EMBO Journal, 14, 461-472.
16. Harbour, J., Lai, S., Whang, P., Gazdar, A., Minna, J. & Kaye, F. (1988) Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science, 241, 353-356.
17. Harlow, E. & Lane, D. (1988) Antibodies: A Laboratory Manual. Cold Spring Harbour Laboratory, New York.
18. Kornblau, S., Chen, N., Giglio, A., O'Brien, S. & Deisseroth, A. (1994a) Retinoblastoma protein expression is frequently altered in chronic lymphocytic leukemia. Cancer Research, 54, 1-5.
19. Kornblau, S., Xu, H., Zhang, W., Hu, S., Beran, M., Smith, T., Hester, J., Estey, E., Benedict, W. & Deisseroth, A. (1994b) Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia. Blood, 84, 256-261.
20. Lee, E., Chang, C., Hu, N., Wang, Y., Lai, C., Herrup, K. & Lee, W.H. (1992) Mice deficient for Rh are nonviable and show defects in neurogenesis and haematopoiesis. Nature, 359, 328-330.
21. Lee, W.H., Bookstein, R., Hong, F., Young, L., Shew, J. & Lee, E.Y.H.P. (1987) Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science, 235, 1394-1399.
22. Lohman, D., Brandt, B., Hopping, W., Passarge, E. & Horsthemke, B. (1994) Spectrum of small length germline mutations in the RB1 gene. Human Molecular Genetics, 3, 2187-2193.
23. Ludlow, J., DeCaprio, J., Huang, C., Lee, W.H., Paucha, E. & Livingston, D. (1989) SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell, 56, 57-65.
24. Marshall, C.J. (1991) Tumor suppressor genes. Cell, 64, 313-326.
25. McFall, R., Sery, T. & Makadon, M. (1977) Characterisation of a new continuous cell line derived from a human retinoblastoma. Cancer Research, 37, 1003-1010.
26. Ohtani-Fujita, N., Fujita, T., Takahashi, R., Robbins, P., Dryja, T. & Sakai, T. (1994) A silencer element in the retinoblastoma tumor-suppressor gene. Oncogene, 9, 1703-1711.
27. Preudhomme, C., Vachee, A., Lepelley, P., Vanrumbeke, M., Zandecki, M., Quesnel, B., Cosson, A. & Fenaux, P. (1994) Inactivation of the retinoblastoma gene appears to be very uncommon in myelodysplastic syndromes. British Journal of Haematology, 87, 61-67.
28. Reissmann, P., Simon, M., Lee, W.H. & Slamon, D. (1989) Studies of the retinoblastoma gene in human sarcomas. Oncogene, 4, 839-844.
29. Sakai, T., Ohtani-Fujita, N., McGee, T., Robbins, P. & Dryja, T. (1991) Oncogenic germline mutations in Sp1 and ATF sites in the human retinoblastoma gene. Nature, 353, 85-86.
30. Sambrook, J., Fritsch, E.F. & Maniatis, T. (1989) Molecular Cloning: a Laboratory Manual. Cold Spring Harbour Laboratory, New York.
31. Shew, J. Lin, B., Chen, P., Tseng, B., Feng, T. & Lee, W.H. (1990) C-terminal truncation of the retinoblastoma gene product leads to functional inactivation. Proceedings of the National Academy of Sciences of the United States of America, 87, 6-10.
32. Tang, J., Yeh, S., Chen, P., Lin, M., Tien, H. & Chen, Y. (1992) Inactivation of the retinoblastoma gene in acute myelogenous leukaemia. British Journal of Haematology, 82, 502-507.
33. T'Ang, A., Varley, J., Chakraborty, S., Murphree, A. & Fung, Y. (1988) Structural rearrangement of the retinoblastoma gene in human breast carcinoma. Science, 242, 263-267.
34. Toguchida, J., Ishizaki, K., Sasaki, M., Ikenaga, M., Sugimoto, M., Kotoura, Y. & Yamamuro, T. (1988) Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma. Cancer Research, 48, 3939-3943.
35. Toguchida, J., McGee, T., Paterson, J., Eagle, J., Tucker, S., Yandell, D. & Dryja, T. (1993) Complete genomic sequence of the human retinoblastoma susceptibility gene. Genomics, 17, 535-543.
36. Towatari, M., Adachi, K., Kato, H. & Saito, H. (1991) Absence of the human retinoblastoma gene product in the megakaryoblastic crisis of chronic myelogenous leukemia. Blood, 78, 2178-2181.
37. Weide, R., Parviz, B., Pfluger, K. & Havemann, K. (1993) Altered expression of the human retinoblastoma gene in monocytic leukaemias. British Journal of Haematology, 83, 428-432.
38. Weide, R., Tiemann, M., Pfluger, K., Koppler, H., Parvizl, B., Wacker, H., Kreipe, H., Havemann, K. & Parwaresch, M. (1994) Altered expression of the retinoblastoma gene product in human high-grade non-Hodgkin's lymphomas. Leukemia, 12, 97-101.
39. Weinberg, R. (1989) The Rb gene and the negative regulation of cell growth. Blood, 74, 529-532.
40. Wheatley, K., Burnett, A., Goldstone, A., Hann, I., Stevens, R., Rees, J. & Gray, R. (1995) A simple, robust and highly predictive prognostic index for the determination of risk directed therapy in acute myeloid leukemia (AML) derived from the United Kingdom Medical Research Council (MRC) AML10 trial. Blood, 86, (Suppl. 1), 598a.
41. Yandell, D., Campbell, T., Dayton, S., Petersen, R., Walton, D., Little, J., McConkie-Rossell, A., Buckley, E. & Dryja, T. (1989) Oncogenic point mutations in the human retinoblastoma gene: their application to genetic counseling. New England Journal of Medicine, 321, 1689-1695.
42. Zhu, Y., Bradbury, D. & Russell, N. (1994) Decreased retinoblastoma protein expression in acute myeloblastic leukaemia is associated with the autonomous proliferation of clonogenic blasts. British Journal of Haematology, 86, 533-539.